Major article| Volume 41, ISSUE 4, P345-348, April 2013

Download started.


Impact of chlorhexidine-impregnated washcloths on reducing incidence of vancomycin-resistant enterococci colonization in hematology–oncology patients

Published:September 13, 2012DOI:


      Daily skin cleansing with washcloths impregnated with chlorhexidine gluconate (CHG) of patients in intensive care unit is associated with reduction in incidence of vancomycin-resistant Enterococci (VRE) acquisition. This study describes the impact on incidence of VRE colonization after the implementation of daily skin cleansing with 2% CHG-impregnated washcloths in hematology–oncology patients.


      In this before-and-after study, we compared the incidence rate of VRE colonization during the baseline period (where routine soap-and-water bathing was used) with the intervention period where patients were cleansed with 2% CHG-impregnated washcloths.


      Acquisition of VRE decreased from 7.8% in the baseline to 3.8% in the intervention period (relative risk, 0.48, 95% confidence interval [CI], 0.21-1.09; P = .07). The crude relative rate of acquisition during the intervention period compared with the baseline period was 0.53 (95% CI, 0.23-1.23; P = .13). Patients who had been a roommate of a patient subsequently found to have VRE were at a significantly increased risk for acquiring VRE (hazard ratio, 18.8, 95% CI, 5.37-66.15; P < .001). However, patients admitted to the same bed number of previously known VRE-colonized patient were not at increased risk of VRE acquisition (hazard ratio, 0.37, 95% CI, 0.11-1.22; P = .10).


      We did not observe a statistically significant reduction in the rate of VRE colonization in association with the use of 2% CHG-impregnated washcloths among hematology–oncology patients.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Uttley A.H.
        • Collins C.H.
        • Naidoo J.
        • George R.C.
        Vancomycin-resistant enterococci.
        Lancet. 1988; 1: 57-58
        • Kamarulzaman A.
        • Tosolini F.A.
        • Boquest A.L.
        • Geddes J.E.
        • Richards M.J.
        Vancomycin-resistant Enterococcus faecium in a liver transplant patient.
        Aust NZ J Med. 1995; 25: 560
        • Bell J.
        • Turnidge J.
        • Coombs G.
        • O'Brien F.
        Emergence and epidemiology of vancomycin-resistant enterococci in Australia.
        Commun Dis Intell. 1998; 22: 249-252
        • Horan T.C.
        • Andrus M.
        • Dudeck M.A.
        CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.
        Am J Infect Control. 2008; 36: 309-332
        • Montecalvo M.A.
        • de Lencastre H.
        • Carraher M.
        • Gedris C.
        • Chung M.
        • VanHorn K.
        • et al.
        Natural history of colonization with vancomycin-resistant Enterococcus faecium.
        Infect Control Hosp Epidemiol. 1995; 16: 680-685
        • Joels C.S.
        • Matthews B.D.
        • Sigmon L.B.
        • Hasan R.
        • Lohr C.E.
        • Kercher K.W.
        • et al.
        Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections.
        Am Surg. 2003; 69: 514-519
        • DiazGranados C.A.
        • Zimmer S.M.
        • Klein M.
        • Jernigan J.A.
        Comparison of mortality associated with vancomycin-resistant and vancomycin-susceptible enterococcal bloodstream infections: a meta-analysis.
        Clin Infect Dis. 2005; 41: 327-333
        • Christiansen K.J.
        • Turnidge J.D.
        • Bell J.M.
        • George N.M.
        • Pearson J.C.
        Prevalence of antimicrobial resistance in Enterococcus isolates in Australia, 2005: report from the Australian Group on Antimicrobial Resistance.
        Commun Dis Intell. 2007; 31: 392-397
        • Rosenberg A.
        • Alatary S.D.
        • Peterson A.F.
        Safety and efficacy of the antiseptic chlorhexidine gluconate.
        Surg Gynecol Obstet. 1976; 143: 789-792
        • Edmiston Jr., C.E.
        • Seabrook G.R.
        • Johnson C.P.
        • Paulson D.S.
        • Beausoleil C.M.
        Comparative of a new and innovative 2% chlorhexidine gluconate-impregnated cloth with 4% chlorhexidine gluconate as topical antiseptic for preparation of the skin prior to surgery.
        Am J Infect Control. 2007; 35: 89-96
        • Climo M.W.
        • Sepkowitz K.A.
        • Zuccotti G.
        • Fraser V.J.
        • Warren D.K.
        • Perl T.M.
        • et al.
        The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial.
        Crit Care Med. 2009; 37: 1858-1865
        • Vernon M.O.
        • Hayden M.K.
        • Trick W.E.
        • Hayes R.A.
        • Blom D.W.
        • Weinstein R.A.
        Chlorhexidine gluconate to cleanse patients in a medical intensive care unit: the effectiveness of source control to reduce the bioburden of vancomycin-resistant enterococci.
        Arch Intern Med. 2006; 166: 306-312
        • Dutka-Malen S.
        • Evers S.
        • Courvalin P.
        Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.
        J Clin Microbiol. 1995; 33: 1434
        • Dixon J.M.
        • Carver R.L.
        Daily chlorohexidine gluconate bathing with impregnated cloths results in statistically significant reduction in central line-associated bloodstream infections.
        Am J Infect Control. 2010; 38: 817-821
        • Evans H.L.
        • Dellit T.H.
        • Chan J.
        • Nathens A.B.
        • Maier R.V.
        • Cuschieri J.
        Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients.
        Arch Surg. 2010; 145: 240-246
        • Huang S.S.
        • Datta R.
        • Platt R.
        Risk of acquiring antibiotic-resistant bacteria from prior room occupants.
        Arch Intern Med. 2006; 166: 1945-1951
        • Datta R.
        • Platt R.
        • Yokoe D.S.
        • Huang S.S.
        Environmental cleaning intervention and risk of acquiring multidrug-resistant organisms from prior room occupants.
        Arch Intern Med. 2011; 171: 491-494
        • Byers K.E.
        • Anglim A.M.
        • Anneski C.J.
        • Germanson T.P.
        • Gold H.S.
        • Durbin L.J.
        • et al.
        A hospital epidemic of vancomycin-resistant Enterococcus: risk factors and control.
        Infect Control Hosp Epidemiol. 2001; 22: 140-147
        • Martinez J.A.
        • Ruthazer R.
        • Hansjosten K.
        • Barefoot L.
        • Snydman D.R.
        Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
        Arch Intern Med. 2003; 163: 1905-1912
        • Zhou Q.
        • Moore C.
        • Eden S.
        • Tong A.
        • McGeer A.
        Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital.
        Infect Control Hosp Epidemiol. 2008; 29: 398-403
        • Kassakian S.Z.
        • Mermel L.A.
        • Jefferson J.A.
        • Parenteau S.L.
        • Machan J.T.
        Impact of chlorhexidine bathing on hospital-acquired infections among general medical patients.
        Infect Control Hosp Epidemiol. 2011; 32: 238-243
        • Bleasdale S.C.
        • Trick W.E.
        • Gonzalez I.M.
        • Lyles R.D.
        • Hayden M.K.
        • Weinstein R.A.
        Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients.
        Arch Intern Med. 2007; 167: 2073-2079